Home › Financial Services › Challenger (ASX:CGF)

Challenger's retirement growth gives TAL more to negotiate over

Financial Services By Claire Turing 4 min read

Challenger has used its 2026 AGM to showcase stronger earnings, record annuity sales and a substantial capital buffer while keeping discussions open with TAL Daiichi Life over its $11.80-per-share approach. The board still does not consider the proposal sufficient to recommend to shareholders.

  • TAL's $11.80-per-share proposal remains non-binding and conditional
  • FY26 normalised NPAT rose 3% to $468 million
  • Ordinary dividend increased 7% to 31.5 cents per share
  • $1.1 billion of excess capital reported at 30 June 2026
  • First-quarter FY27 sales rose 52% to $4.4 billion

TAL offer remains below Challenger board's threshold

Challenger Limited (ASX:CGF) has presented shareholders with a familiar tension at its 2026 annual general meeting: a retirement-income business reporting strong operating momentum, but also weighing a takeover approach that its board says does not yet reflect the company's value and prospects.

TAL Daiichi Life Australia has proposed acquiring the 79.5% of Challenger it does not already own through a scheme of arrangement at $11.80 per share. The approach remains non-binding and conditional. Challenger said its board intends to engage with TAL to determine whether a proposal can be reached that could be recommended, while stressing that there is no certainty of a binding offer or completed transaction. The board's position follows the TAL takeover discussions, which earlier coverage reported had been left open despite the $11.80 proposal being considered too low to recommend.

Shareholders do not need to take action at this stage. Challenger also said its recently launched $300 million on-market buy-back was paused on 19 October after the TAL approach, with any resumption dependent on what the board considers appropriate.

FY26 profit and dividends move higher

The board used the meeting to underline the financial case for remaining independent. FY26 normalised net profit after tax rose 3% to $468 million, while normalised earnings per share increased 3% to 68.1 cents. Record annuity sales supported the result, although the release did not provide a single quantified bridge between sales growth and earnings.

Challenger declared a fully franked ordinary dividend of 31.5 cents per share, up 7% on the previous year, alongside a 1.5-cent fully franked special dividend. It also completed a $150 million buy-back during the year, purchasing approximately 16 million shares, before announcing the additional program that is now paused. The capital position remained a central part of the investment argument, with more than $1.1 billion of excess capital reported at 30 June 2026.

The capital figures require some care. Challenger said the reported 1.50 times pro-forma PCA ratio under the new APRA capital standards was based on assumed application of those standards and was not audited. Management nevertheless described the framework, which took effect on 1 July, as improving capital resilience and creating greater flexibility for growth in longevity products.

Retirement platform gains momentum in early FY27

“Nick Hamilton”Caption and image © Challenger Limited. From “2026 AGM Chair and CEO addresses and presentation”, 29 Oct 2026.

Chief executive Nick Hamilton said Challenger's retirement partnerships with Insignia, BT and Colonial First State, together with integrations into Iress Xplan and Informed Financial Future, are designed to place guaranteed lifetime income inside the tools advisers already use. The company also pointed to new institutional funding through its Challenger Annuity-Backed Notes program, offshore reinsurance through Calix Re and the proposed merger of Fidante with Channel Capital.

The early FY27 numbers provide the clearest immediate test of that strategy. First-quarter annuity sales increased 72% year on year to $2.8 billion, total sales rose 52% to $4.4 billion and assets under management reached $31.9 billion, up 5% from the June quarter. Challenger is targeting $50 billion of assets by 2030, compared with $31 billion at the end of FY26.

Those figures strengthen the board's argument that Challenger's growth prospects extend beyond the current offer. They do not, however, settle the valuation question that now sits at the centre of the TAL discussions. The next material disclosure is likely to determine whether negotiations produce a revised proposal, stall, or move towards a binding transaction.

Bottom Line?

Challenger's operating momentum gives the board room to negotiate, but the $11.80 offer remains a live test of how TAL values that growth.

Questions in the middle?

  • Will TAL return with a revised proposal that Challenger's board can recommend?
  • When, and on what terms, could Challenger resume the paused $300 million buy-back?
  • Can annuity sales and AUM growth continue at the pace needed to support the company's $50 billion 2030 target?

Sources